Education
About Us
Working with TipRanks
Follow Us
Andrew Fromkin Insider Profile
11 Followers
Andrew Fromkin, Director at Tobira Therapeutics, holds 85.85K shares in Immunovant (Ticker: IMVT), holds 150.00 shares in Tobira Therapeutics (Ticker: TBRA), holds ― shares in Radius Health (Ticker: ~RDUS).
Andrew Fromkin Tobira Therapeutics (TBRA)Director
Tobira Therapeutics (TBRA)
Director
Not Ranked
Andrew Fromkin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Andrew Fromkin holds in companies
Most Profitable Insider Trade
The most profitable trade made by Andrew Fromkin
Andrew Fromkin's Trading History
Tobira Therapeutics
Nov 03, 2016
―
Uninformative Sell
―
$6.31K
Immunovant
Dec 03, 2025
Director
Uninformative Sell
517.19K
$2.36M
Radius Health
―
―
―
―
List of latest transactions for each holding click on a transaction to see Andrew Fromkin's performance on stock
You May Also Like
Andrew Fromkin insider profile FAQ
What is the percentage of profitable transactions made by Andrew Fromkin?
The percentage of profitable transactions made by Andrew Fromkin is ―.
What is the average return per transaction made by Andrew Fromkin?
The average return per transaction made by Andrew Fromkin is ―.
What stocks does Andrew Fromkin hold?
Andrew Fromkin holds: TBRA, IMVT, ~RDUS stocks.
What was Andrew Fromkin’s latest transaction?
Andrew Fromkin latest transaction was an Uninformative Sell of $517.19K.
What was Andrew Fromkin's most profitable transaction?
Andrew Fromkin’s most profitable transaction was an Informative Buy of IMVT stock on August 11, 2021. The return on the trade was -34.70%.
What is Andrew Fromkin's role in Tobira Therapeutics?
Andrew Fromkin's role in Tobira Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.